A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function

NCT05094934 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Chronic Kidney Disease

Interventions

DRUG: NNC0385-0434 A 100 mg

Sponsor

Novo Nordisk A/S